Investment Rating - The report maintains a "Buy" rating for Hong Kong Exchanges and Clearing Limited (0388.HK) [2][9]. Core Views - In the medium to long term, the report anticipates that a series of connectivity policies will enhance the basic conditions for recovery in the capital market, leading to sustained liquidity in the Hong Kong stock market and an increase in overall market activity and valuation [2][6]. - The company is projected to achieve revenues and other income of HKD 266.63 billion, 285.26 billion, and 304.86 billion for the years 2025, 2026, and 2027 respectively, with net profit attributable to shareholders of HKD 160.57 billion, 172.00 billion, and 184.36 billion for the same years, corresponding to PE ratios of 26.91, 25.12, and 23.44 [2][6]. Summary by Sections Q1 Performance - In Q1 2025, the company reported revenues and other income of HKD 68.57 billion, a year-on-year increase of 31.84%, and a net profit attributable to shareholders of HKD 40.77 billion, up 37.3% year-on-year [6][9]. - Revenue growth was driven by strong performance across various fee structures, with trading and trading system usage fees increasing by 60.29%, listing fees by 11.78%, and settlement and clearing fees by 56.32% [6][9]. Market Activity - The report highlights a significant increase in trading activity in the cash, derivatives, and commodities markets, with daily average turnover in the cash market rising by 153.0% year-on-year and daily average turnover in the Stock Connect increasing by 43.7% [6][9]. - The increase in trading activity led to a 69.9% year-on-year growth in settlement and clearing fee income [6][9]. Future Projections - The report projects that the company will continue to benefit from enhanced market conditions and connectivity policies, with expected revenue growth and profitability over the next few years [2][6]. - Specific revenue and profit forecasts for 2025 to 2027 indicate a positive outlook for the company's financial performance [10].

Group 1 - The Hong Kong IPO market is experiencing a strong recovery after nearly two years of stagnation, with 147 companies currently queued for listing, including major A-share companies like CATL and Hengrui Medicine [1][4] - The surge in IPOs is driven by multiple favorable factors, leading to a rare "submission wave" and fundraising peak, attracting renewed attention from investors, brokers, and institutional funds [3][4] - In April, one A-share company has launched its IPO in Hong Kong, and 11 companies have updated or submitted their applications, indicating a trend influenced by tightened financing channels in A-shares and valuation recovery in Hong Kong [4][6] Group 2 - CATL, a global leader in power batteries, has passed the listing hearing on April 10 and plans to raise up to $5 billion (approximately HKD 39 billion), potentially marking the largest IPO in Hong Kong since Kuaishou's listing in 2021 [6][7] - The IPO of CATL is expected to reshape Hong Kong's position in the global capital market and may serve as a milestone for the return and internationalization of Chinese enterprises [7][9] - Hong Kong Exchanges and Clearing reported record high revenues and profits for Q1 2025, with 17 companies listed and a total fundraising amount of HKD 18.7 billion, a nearly fourfold year-on-year increase [9] Group 3 - Investors and institutions are set to benefit from the increased activity in the Hong Kong stock market, which will provide more opportunities for new listings and valuation recovery, particularly for quality leading companies like CATL and Hengrui Medicine [10][11] - The revival of IPOs indicates a comprehensive recovery for underwriting, distribution, and market-making businesses, marking a significant rebound in these sectors [11][12] - Chain consumption brands are emerging as new highlights in the Hong Kong stock market, with companies like Pop Mart and Mixue Ice City gaining significant attention and market re-evaluation [12][13] Group 4 - The success of chain consumption brands is attributed to their unique business models and significant growth potential, supported by the long-term optimism of the Hong Kong Stock Exchange towards the consumption sector [13][14] - These brands are not only seeking financing through IPOs but also aiming for international brand expansion, leveraging capital market support to enhance market share and brand influence [13][14] - The current situation in the Hong Kong IPO market reflects a strategic migration of Chinese enterprises in the context of globalization and a new capital market landscape [14]

Core Insights - Hong Kong's IPO fundraising has significantly increased, with 17 new listings raising approximately HKD 177 billion (around USD 20 billion) in the first quarter of 2025, more than doubling the amount from the previous year [1] - The follow-on market has also become more active, raising over USD 18 billion in the first quarter of 2025, a 20-fold increase year-on-year, with notable transactions from BYD and Xiaomi [1] - There is a growing trend of A+H listings, with around 30 companies planning to list in Hong Kong, particularly in the technology and biotech sectors [2] Market Trends - The new economy, artificial intelligence, renewable energy, and tech unicorns are key focus areas for new listings in Hong Kong [2] - Increased dialogue with ASEAN companies has led to successful listings from several firms in the region, indicating a strong interest in the Hong Kong market [2] - Hong Kong is also targeting the Middle East, with plans to open an office in Riyadh and strengthen ties with the Saudi stock exchange [3] Regulatory and Structural Developments - Hong Kong has completed consultations on IPO pricing, aiming to enhance the pricing process and distribution structures [4] - The Hong Kong Securities and Futures Commission and the exchange have announced measures to improve the transparency of the new listing application process [4] - Initiatives like the "REIT Connect" and a dedicated line for tech companies are in preparation to further optimize the listing environment [4]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company achieved record high performance in Q1 2025, with total revenue of HKD 68.6 billion, a year-on-year increase of 31.8% and a quarter-on-quarter increase of 7.5%. The net profit attributable to shareholders was HKD 40.8 billion, up 37.3% year-on-year and 7.9% quarter-on-quarter [4][5] - The increase in revenue and profit is primarily driven by heightened trading activity in the Hong Kong stock market, supported by innovations in artificial intelligence and other developments [5] - The report anticipates that the return of Chinese concept stocks to Hong Kong could inject new trading volume into the market [7] Summary by Sections Financial Performance - In Q1 2025, the company's main business revenue reached HKD 63.2 billion, reflecting a year-on-year growth of 35.6% and a quarter-on-quarter growth of 5.0% [4] - The trading fees, system usage fees, and settlement fees totaled HKD 41.3 billion, accounting for 60.2% of total revenue, with a year-on-year increase of 58.7% [5] - Investment income netted HKD 13.3 billion, representing 19.4% of total revenue, with a slight year-on-year decrease of 0.7% but a quarter-on-quarter increase of 11.2% [5] Market Activity - The average daily trading volume for Hong Kong stock securities reached HKD 2,427 billion, a year-on-year increase of 144.2% [5] - The number of new listings in Q1 2025 was 17, a year-on-year increase of 41.7%, raising a total of HKD 187 billion, which is a 289.6% increase year-on-year [7] Future Outlook - The report maintains profit forecasts for 2025-2027 at HKD 150 billion, HKD 156 billion, and HKD 165 billion respectively, with a corresponding PE ratio of 29X, 28X, and 26X [7][9]

Group 1 - JPMorgan's stake in Alibaba-W increased from 5.98% to 6.02% as of April 28 [1] - The average share price for this transaction was HKD 115.7105 [1]

智通财经5月2日电，香港交易所信息显示，贝莱德（BlackRock）在蒙牛乳业的持股比例于04月28日从 4.93%升至5.14%，平均股价为19.0401港元。 ...

香港交易所信息显示， 摩根大通（JPMorgan）在 美团-W的持股比例于04月28日从5.12%降至5.10%。 ...

高盛(GS.N)：上调香港交易所(00388.HK)目标价2%至386港元，维持买入评级。 ...

Group 1 - The Hang Seng Index opened up 0.33% and the Hang Seng Tech Index opened up 0.48%, with notable gains in Rainy Food (over 11%) and other companies like BYD, Hong Kong Exchanges, Alibaba, Li Auto, SMIC, and Xiaomi (over 1%) [1] - Everbright Securities suggests that the current valuation of the Hang Seng Index is at a medium-low level, while the Hang Seng Tech Index is at a historical low, indicating high investment cost-effectiveness for Hong Kong stocks [1] - Ping An Securities highlights that domestic large models, represented by DeepSeek, have performance comparable to leading overseas models at a lower cost, with applications across various sectors including education, finance, and healthcare [1] Group 2 - Goldman Sachs reports that the first-quarter pre-provision profits and net profits of major state-owned banks in China fell slightly short of expectations, with net profits of other large state-owned banks down approximately 2% to 4% year-on-year [2] - Most domestic banks, except for Agricultural Bank, did not see strong loan growth as anticipated, raising concerns among investors about the sustainability of annual dividends [2]

每经记者 黄婉银 实习生 刘姝 每经编辑 魏官红 4月30日，香港交易所（HK00388，股价340.8港元，市值4321亿港元；以下简称"港交所"）举行股东周 年大会，港交所主席唐家成、行政总裁陈翊庭、首席营运总监及财务总监刘碧茵等高管出席并答股东 问。 同日，港交所还发布了2025年第一季度业绩报告。港交所一季度的收益和溢利均创历史季度新高，同 比、环比均实现增长。其中，收益实现近69亿港元，同比上升32%，较2024年第四季度上升7%；股东 应占溢利约为41亿港元，同比上升37%，较2024年第四季度上升8%。 股东大会上讨论的焦点主要围绕港交所是否续聘普华永道为核数师、斥资63亿港元向香港置地购买香港 中环交易广场办公楼物业等事项。 有股东提问，此前部分上市公司已经与普华永道方面解约，港交所是否仍会继续聘用其为核数师。刘碧 茵回应称，集团规模较大，要更换核数师会有详细的流程，2025年度不会更换，内部会商讨到2026年是 否更换核数师。 收购中环物业反映对中国市场的信心 在股东大会上，有股东提到，港交所要自主研发衍生产品交易平台。陈翊庭对此表示，预计将会投资10 亿港元至领航星衍生产品平台（ODP）。 ...